Rivastigmine 3M Health Care Ltd Unione Europea - italiano - EMA (European Medicines Agency)

rivastigmine 3m health care ltd

3m health care limited - rivastigmina - malattia di alzheimer - psychoanaleptics, , anticolinesterasici - trattamento sintomatico della demenza di alzheimer da lieve a moderatamente grave.

Blincyto Unione Europea - italiano - EMA (European Medicines Agency)

blincyto

amgen europe b.v. - blinatumomab - linfoma di leucemia linfoblastica a cellule precursori - agenti antineoplastici - blincyto is indicated as monotherapy for the treatment of adults with cd19 positive relapsed or refractory b precursor acute lymphoblastic leukaemia (all). patients with philadelphia chromosome positive b-precursor all should have failed treatment with at least 2 tyrosine kinase inhibitors (tkis) and have no alternative treatment options. blincyto is indicated as monotherapy for the treatment of adults with philadelphia chromosome negative cd19 positive b-precursor all in first or second complete remission with minimal residual disease (mrd) greater than or equal to 0. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with philadelphia chromosome negative cd19 positive b precursor all which is refractory or in relapse after receiving at least two prior therapies or in relapse after receiving prior allogeneic haematopoietic stem cell transplantation. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with high-risk first relapsed philadelphia chromosome negative cd19 positive b-precursor all as part of the consolidation therapy (see section 4.

Luna Care Italia - italiano - Ministero della Salute

luna care

bayer ag - granulare idrodispersibile (wg) - fluopyram; 5%; fosetyl; alluminio; 66,6% - fungicidi

BACTRIM Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

bactrim

eumedica pharmaceuticals gmbh - associazioni di sulfamidici con trimetoprim, inclusi i derivati - associazioni di sulfamidici con trimetoprim, inclusi i derivati

IOBENGUANO [131 I] GE HEALTHCARE T Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

iobenguano [131 i] ge healthcare t

ge healthcare s.r.l. - iodio-131i-iobenguano - iodio-131i-iobenguano